|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$72.31 |
$74.56 |
$70.93 |
$72.37 |
2.19M | 04/22/2024 |
$73.68 |
$75.14 |
$72.02 |
$74.54 |
1.93M | 04/23/2024 |
$75.06 |
$76.89 |
$73.69 |
$74.01 |
826.60K | 04/24/2024 |
$73.74 |
$74.12 |
$72.41 |
$73.12 |
736.50K | 04/25/2024 |
$72.46 |
$72.78 |
$71.35 |
$72.13 |
658.80K |
|
Intra-Cellular Therapies is a biopharmaceutical company focused on the discovery, clinical development and commercialization of small molecule drugs that address medical needs mainly in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. Co.'s product candidate, CAPLYTA (lumateperone) has been approved for the treatment of schizophrenia in adults. Co. is developing ITI-1284, an oral disintegrating tablet for sublingual administration for the treatment of behavioral disturbances in patients with dementia and dementia-related psychosis and for the treatment of certain depressive disorders in the elderly. | |
|
Intra-Cellular Therapies (ITCI) has the following price history information. Looking back at ITCI historical stock prices for the last five trading days, on April 19, 2024, ITCI opened at $72.31, traded as high as $74.56 and as low as $70.93, and closed at $72.37. Trading volume was a total of 2.19M shares. On April 22, 2024, ITCI opened at $73.68, traded as high as $75.14 and as low as $72.02, and closed at $74.54. Trading volume was a total of 1.93M shares. On April 23, 2024, ITCI opened at $75.06, traded as high as $76.89 and as low as $73.69, and closed at $74.01. Trading volume was a total of 826.60K shares. On April 24, 2024, ITCI opened at $73.74, traded as high as $74.12 and as low as $72.41, and closed at $73.12. Trading volume was a total of 736.50K shares. On April 25, 2024, ITCI opened at $72.46, traded as high as $72.78 and as low as $71.35, and closed at $72.13. Trading volume was a total of 658.80K shares.
ITCI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Intra-Cellular Therapies shares, starting with a $10,000 purchase of ITCI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$16.54 |
|
End price/share: |
$72.13 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
336.09% |
|
Average Annual Total Return: |
15.87% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$43,604.85 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $72.37 | 04/22/2024 | $74.54 | 04/23/2024 | $74.01 | 04/24/2024 | $73.12 | 04/25/2024 | $72.13 |
|
|